Avenue Therapeutics, Inc.
ATXI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001644963
No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Avenue Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 17 | 19 | +2 |
| Shares | 1.04M | 674.6K | −367.6K (−35.3%) |
| Value | $503.0K | $181.0K | −$322.0K (−64.0%) |
New holders (6)
Institutions that held Avenue Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 124,400 | $34.0K | 0.00% |
| HRT Financial LP | 39,100 | $10.0K | 0.00% |
| Susquehanna International Group, LLP | 25,707 | $7.00K | 0.00% |
| Cetera Advisor Networks LLC | 11,392 | $3.00K | 0.00% |
| JPMorgan Chase & Co | 1 | $0 | 0.00% |
| Citigroup Inc | 500 | $0 | 0.00% |
Sold out (4)
Institutions that held Avenue Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 117,674 | $57.0K |
| Virtu Financial LLC | 58,004 | $28.0K |
| Bank of America Corp | 104 | $0 |
| Morgan Stanley | 1,002 | $0 |